Imaging timing after glioblastoma surgery (INTERVAL-GB): protocol for a UK and Ireland, multicentre retrospective cohort study

INTRODUCTION: Glioblastoma is the most common malignant primary brain tumour with a median overall survival of 12–15 months (range 6–17 months), even with maximal treatment involving debulking neurosurgery and adjuvant concomitant chemoradiotherapy. The use of postoperative imaging to detect progres...

Descripción completa

Detalles Bibliográficos
Autores principales: Gillespie, Conor S, Bligh, Emily R, Poon, Michael T C, Solomou, Georgios, Islim, Abdurrahman I, Mustafa, Mohammad A, Rominiyi, Ola, Williams, Sophie T, Kalra, Neeraj, Mathew, Ryan K, Booth, Thomas C, Thompson, Gerard, Brennan, Paul M, Jenkinson, Michael D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472166/
https://www.ncbi.nlm.nih.gov/pubmed/36100297
http://dx.doi.org/10.1136/bmjopen-2022-063043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472166/
https://www.ncbi.nlm.nih.gov/pubmed/36100297
http://dx.doi.org/10.1136/bmjopen-2022-063043

Ejemplares similares